Market Place
Sourcing Support
Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
09 Oct 2023 //
ECONOMIC TIMES
Juno Pharma Acquires Omega Propelling Canada’s Pharma Industry Forward
15 May 2023 //
BUSINESSWIRE
Juno Pharmaceuticals receives approval to import Eptifibatide
29 Mar 2023 //
BUSINESSWIRE
Juno receives approval from Health Canada to import Amoxicillin
04 Jan 2023 //
BUSINESSWIRE
Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharma
24 Feb 2022 //
BUSINESSWIRE
Backed by $700M, startup led by vets of Genentech, UCSF, Juno has cell & gene
25 Jun 2020 //
BIZJOURNALS
Juno, WuXi JV in China score $100M in fresh funding as it sets stage
11 Jun 2020 //
ENDPTS
Motion denied: Gilead still on the hook $1.5B in damages CAR-T patent dispute
02 Apr 2020 //
ENDPTS
FDA faults U.S. plant for releasing out-of-spec eczema treatment
13 Dec 2019 //
FIERCE PHARMA
Kite, Juno locked in high-stakes CAR-T patent fight
12 Dec 2019 //
FIERCE PHARMA
Editas and Celgene sub Juno are tackling hottest immunotherapy cells
13 Nov 2019 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.